C&EN5d
Long COVID studies stymied by pharma’s lack of cooperation
Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.
Hosted on MSN2mon
Ocrevus and Its Link to Progressive Multifocal Leukoencephalopathy (PML)
concerns have arisen over its association with a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). Ocrevus is specifically designed to treat MS by ...
The Scientist7mon
Genentech pulls Raptiva
Genentech withdrew its psoriasis drug Raptiva from the market yesterday, citing the risk of developing progressive multifocal leukoencephalopathy (PML), a rare, often fatal brain infection. The drug ...
Medscape1mon
Stop Disease-Modifying Therapy in Stable MS: Yes or No?
In addition, serious risks — such as progressive multifocal leukoencephalopathy associated with natalizumab — can significantly influence the decision to discontinue treatment. Many patients ...
Nature9y
JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications
Extended application of allogeneic stem cell transplantation (alloSCT) is expected to increase the frequency of JC polyomavirus (JCPyV)-related progressive multifocal leukoencephalopathy (PML).